Mereo Biopharma Group Plc ADR (NASDAQ: MREO) kicked off on Monday, down -87.65% from the previous trading day, before settling in for the closing price of $2.31. Over the past 52 weeks, MREO has traded in a range of $1.47-$3.84.
Healthcare Sector giant saw their annual sales surged by 34.82% over the last five years. While this was happening, its average annual earnings per share was recorded 11.90%. With a float of $137.51 million, this company’s outstanding shares have now reached $159.10 million.
Mereo Biopharma Group Plc ADR (MREO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Mereo Biopharma Group Plc ADR is 13.57%, while institutional ownership is 57.43%.
Mereo Biopharma Group Plc ADR (MREO) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.01 earnings per share (EPS), higher than consensus estimate (set at -0.01) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 61.84% during the next five years compared to 34.82% growth over the previous five years of trading.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Trading Performance Indicators
Take a look at Mereo Biopharma Group Plc ADR’s (MREO) current performance indicators. Last quarter, stock had a quick ratio of 8.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 89.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.02 in one year’s time.
Technical Analysis of Mereo Biopharma Group Plc ADR (MREO)
Analysing the last 5-days average volume posted by the [Mereo Biopharma Group Plc ADR, MREO], we can find that recorded value of 49.95 million was better than the volume posted last year of 2.66 million. As of the previous 9 days, the stock’s Stochastic %D was 60.90%.
During the past 100 days, Mereo Biopharma Group Plc ADR’s (MREO) raw stochastic average was set at 3.94%, which indicates a significant increase from 3.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was higher than the 0.11 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.94, while its 200-day Moving Average is $2.09. Now, the first resistance to watch is $0.33. This is followed by the second major resistance level at $0.37. The third major resistance level sits at $0.43. If the price goes on to break the first support level at $0.22, it is likely to go to the next support level at $0.16. Now, if the price goes above the second support level, the third support stands at $0.12.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Key Stats
The company with the Market Capitalisation of 45.41 million has total of 159,132K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -43,250 K annual income. Company’s last quarter sales were recorded 500 K and last quarter income was -14,620 K.
